These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 22446083)

  • 1. Bile-based detection of extrahepatic cholangiocarcinoma with quantitative DNA methylation markers and its high sensitivity.
    Shin SH; Lee K; Kim BH; Cho NY; Jang JY; Kim YT; Kim D; Jang JJ; Kang GH
    J Mol Diagn; 2012; 14(3):256-63. PubMed ID: 22446083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA Methylation Markers Improve the Sensitivity of Endoscopic Retrograde Cholangiopancreatography-Based Brushing Cytology in Extrahepatic Cholangiocarcinoma.
    Prachayakul V; Kanchanapermpoon J; Thuwajit C; Boonyaarunnate T; Pongpaibul A; Chobson P; Thuwajit P
    Technol Cancer Res Treat; 2017 Dec; 16(6):1252-1258. PubMed ID: 29484968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Identification of a novel bile marker clusterin and a public online prediction platform based on deep learning for cholangiocarcinoma.
    Gao L; Lin Y; Yue P; Li S; Zhang Y; Mi N; Bai M; Fu W; Xia Z; Jiang N; Cao J; Yang M; Ma Y; Zhang F; Zhang C; Leung JW; He S; Yuan J; Meng W; Li X
    BMC Med; 2024 Apr; 22(1):179. PubMed ID: 38679726
    [No Abstract]   [Full Text] [Related]  

  • 4. Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma.
    Andresen K; Boberg KM; Vedeld HM; Honne H; Jebsen P; Hektoen M; Wadsworth CA; Clausen OP; Lundin KE; Paulsen V; Foss A; Mathisen Ø; Aabakken L; Schrumpf E; Lothe RA; Lind GE
    Hepatology; 2015 May; 61(5):1651-9. PubMed ID: 25644509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile.
    Vedeld HM; Grimsrud MM; Andresen K; Pharo HD; von Seth E; Karlsen TH; Honne H; Paulsen V; Färkkilä MA; Bergquist A; Jeanmougin M; Aabakken L; Boberg KM; Folseraas T; Lind GE
    Hepatology; 2022 Jan; 75(1):59-73. PubMed ID: 34435693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common DNA methylation changes in biliary tract cancers identify subtypes with different immune characteristics and clinical outcomes.
    Qiu Z; Ji J; Xu Y; Zhu Y; Gao C; Wang G; Li C; Zhang Y; Zhao J; Wang C; Wen X; Zhang Z; Li B; Zhang Z; Cai S; Li B; Jiang X
    BMC Med; 2022 Feb; 20(1):64. PubMed ID: 35130881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiomic Analysis Reveals Comprehensive Tumor Heterogeneity and Distinct Immune Subtypes in Multifocal Intrahepatic Cholangiocarcinoma.
    Chen S; Xie Y; Cai Y; Hu H; He M; Liu L; Liao C; Wang Y; Wang J; Ren X; Zeng Q; Peng H; Shen S; Li S; Li D; Lai J; Peng B; Ren J; Kuang M; Peng S
    Clin Cancer Res; 2022 May; 28(9):1896-1910. PubMed ID: 34526363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome and DNA methylation analysis reveals molecular mechanisms underlying intrahepatic cholangiocarcinoma progression.
    Peng Y; Meng G; Sheng X; Gao H
    J Cell Mol Med; 2021 Jul; 25(13):6373-6387. PubMed ID: 34013637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis - The promise of DNA methylation and molecular biomarkers.
    Vedeld HM; Folseraas T; Lind GE
    JHEP Rep; 2020 Oct; 2(5):100143. PubMed ID: 32939446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
    Wardell CP; Fujita M; Yamada T; Simbolo M; Fassan M; Karlic R; Polak P; Kim J; Hatanaka Y; Maejima K; Lawlor RT; Nakanishi Y; Mitsuhashi T; Fujimoto A; Furuta M; Ruzzenente A; Conci S; Oosawa A; Sasaki-Oku A; Nakano K; Tanaka H; Yamamoto Y; Michiaki K; Kawakami Y; Aikata H; Ueno M; Hayami S; Gotoh K; Ariizumi SI; Yamamoto M; Yamaue H; Chayama K; Miyano S; Getz G; Scarpa A; Hirano S; Nakamura T; Nakagawa H
    J Hepatol; 2018 May; 68(5):959-969. PubMed ID: 29360550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma.
    Jusakul A; Cutcutache I; Yong CH; Lim JQ; Huang MN; Padmanabhan N; Nellore V; Kongpetch S; Ng AWT; Ng LM; Choo SP; Myint SS; Thanan R; Nagarajan S; Lim WK; Ng CCY; Boot A; Liu M; Ong CK; Rajasegaran V; Lie S; Lim AST; Lim TH; Tan J; Loh JL; McPherson JR; Khuntikeo N; Bhudhisawasdi V; Yongvanit P; Wongkham S; Totoki Y; Nakamura H; Arai Y; Yamasaki S; Chow PK; Chung AYF; Ooi LLPJ; Lim KH; Dima S; Duda DG; Popescu I; Broet P; Hsieh SY; Yu MC; Scarpa A; Lai J; Luo DX; Carvalho AL; Vettore AL; Rhee H; Park YN; Alexandrov LB; Gordân R; Rozen SG; Shibata T; Pairojkul C; Teh BT; Tan P
    Cancer Discov; 2017 Oct; 7(10):1116-1135. PubMed ID: 28667006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant DNA Methylation as a Biomarker and a Therapeutic Target of Cholangiocarcinoma.
    Nakaoka T; Saito Y; Saito H
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28545228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypermethylation of
    Branchi V; Schaefer P; Semaan A; Kania A; Lingohr P; Kalff JC; Schäfer N; Kristiansen G; Dietrich D; Matthaei H
    Clin Epigenetics; 2016; 8():133. PubMed ID: 27999621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).
    Banales JM; Cardinale V; Carpino G; Marzioni M; Andersen JB; Invernizzi P; Lind GE; Folseraas T; Forbes SJ; Fouassier L; Geier A; Calvisi DF; Mertens JC; Trauner M; Benedetti A; Maroni L; Vaquero J; Macias RI; Raggi C; Perugorria MJ; Gaudio E; Boberg KM; Marin JJ; Alvaro D
    Nat Rev Gastroenterol Hepatol; 2016 May; 13(5):261-80. PubMed ID: 27095655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advancement in Diagnosis of Biliary Tract Cancer through Pathological and Molecular Classifications.
    Lee SH; Song SY
    Cancers (Basel); 2024 May; 16(9):. PubMed ID: 38730713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies.
    Catanzaro E; Gringeri E; Burra P; Gambato M
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation in cell plasticity and malignant transformation in liver diseases.
    Kim M; Delgado E; Ko S
    Pharmacol Ther; 2023 Jan; 241():108334. PubMed ID: 36535346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular diagnosis of pancreatobiliary tract cancer by detecting mutations and methylation changes in bile samples.
    He S; Zeng F; Yin H; Wang P; Bai Y; Song Q; Chu J; Huang Z; Liu Y; Liu H; Chen Q; Liu L; Zhou J; Hu H; Li X; Li T; Wang G; Cai J; Jiao Y; Zhao H
    EClinicalMedicine; 2023 Jan; 55():101736. PubMed ID: 36425869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis Biomarkers of Cholangiocarcinoma in Human Bile: An Evidence-Based Study.
    Bao F; Liu J; Chen H; Miao L; Xu Z; Zhang G
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology.
    Manne A; Woods E; Tsung A; Mittra A
    Front Oncol; 2021; 11():768009. PubMed ID: 34868996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.